CHEST Annual Meeting 2020
Solriamfetol is indicated to treat excessive daytime sleepiness (EDS) due to obstructive sleep apnea and has been proven ...
Chronic obstructive pulmonary disease (COPD) is a risk factor for lung cancer and may impact how patients’ cancer is ...
Patients with chronic respiratory failure due to chronic obstructive pulmonary disease (COPD-CRF) have a greater risk of ...
During a live discussion at the CHEST Annual Meeting 2020 titled “Sleep Disorders – New Insights Into the ...
Chronic obstructive pulmonary disease (COPD) remains a significant cause of morbidity and mortality in the United ...
A retrospective study observed the effect of pulmonary hypertension (PH) in patients hospitalized with acute ...
A study presented at the CHEST Annual Meeting 2020 assessed the prevalence of sleep disordered breathing (SDB) among ...
During a live discussion at the CHEST Annual Meeting 2020 titled “Sleeping Disorders – Advances Across the ...
Data have suggested that non-white patients with pulmonary sarcoidosis have a greater risk of pulmonary hypertension, ...
The prevalence of obstructive sleep apnea (OSA) is on the rise. This increase showcases the need to understand the ...
A case report presented at the CHEST Annual Meeting 2020 highlighted an example of a multidisciplinary team approach to ...
Sleep disordered breathing (SDB) is not uncommon in hospitalized patients with congestive heart failure (CHF). But ...
A study presented as part of the CHEST Annual Meeting 2020 assessed sleep and mental health disorders among patients ...
According to the National Heart, Lung, and Blood institute, patients with severe asthma (SA) should receive care from an ...
Obstructive sleep apnea (OSA) is not uncommon in hospitalized patients with heart failure and is an independent risk ...
The COVID-19 pandemic spotlighted the use of telemedicine, notably in critical care, but the tele-intensive care unit ...
Advertisement
Advertisement
